X4 Pharmaceuticals (XFOR) Receivables (2019 - 2025)
X4 Pharmaceuticals (XFOR) posted Receivables of $573000.0 for Q4 2025, down 64.32% on a QoQ basis from $1.6 million in Q3 2025, and down 66.49% year-over-year from $1.7 million in Q4 2024.
X4 Pharmaceuticals (XFOR) Receivables (2019 - 2025) Analysis & Trends
X4 Pharmaceuticals' Receivables history runs 5 years deep, the most recent figure standing at $573000.0 for Q4 2025.
- Quarterly Receivables fell 66.49% year-over-year to $573000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $573000.0 (down 66.49% YoY) and the FY2025 annual result came in at $573000.0, down 66.49% from the prior year.
- Receivables was $573000.0 for Q4 2025 at X4 Pharmaceuticals, down from $1.6 million in the prior quarter.
- Across five years, Receivables topped out at $1.9 million in Q2 2025 and bottomed at $562000.0 in Q4 2023.
- A 3-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2024 — Receivables jumped 204.27% — and 2025, when it plunged 66.49%.
- X4 Pharmaceuticals' Receivables stood at $562000.0 in 2023, then soared by 204.27% to $1.7 million in 2024, then slumped by 66.49% to $573000.0 in 2025.
- Business Quant data shows XFOR's Receivables at $573000.0 in Q4 2025, $1.6 million in Q3 2025, and $1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 573,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 854,000.00 |
| Dec 31, 2023 | 562,000.00 |
| Sep 30, 2020 | 3.63 Mn |
| Jun 30, 2020 | 3.51 Mn |
| Mar 31, 2020 | 3.42 Mn |
| Dec 31, 2019 | 2.00 Mn |